MEM 2025, page-137

I bel8eve it was all combined with the monash trial, so yes completed. The issue with all bio stocks is time. It always takes so long to do anything. Then x 2 in Japan as they are risk adverse. So dont expect much from them till the data is confirmed, not the preliminary results that should be with us sometime in Feb? (Early march?) Rhe best way forward from here will be one of these companies testing. The way Vitrolife stalled i actually hope that Heranova come over the top with an offer that c9vers all of Asia. Teach Vitrolife to muck about. Remember that the swim up was bought by coopers surgial, so if Vitrolife lose to Heranova, we may see who has the deepest pockets in a bidding war. But all in due time.